Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 750 participants.
Also called NCT02830152
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 750 participants
- Sponsor
- Registry
-
NCT02830152
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark, Finland, Norway, Sweden
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02830152. Randomized; single masking; primary purpose prevention. Start 2017-05-03 (actual); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage
- Condition
- Atrial Fibrillation
- Condition
- Stroke
- Condition
- Intracerebral Hemorrhage
- Intervention (Device)
- LAAO
- Intervention (Drug)
- Medical Therapy
- Lead sponsor
- Karolinska Institutet
- Collaborator
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct02830152- Content hash
106f81ae7a0faff9968208846d2e8a7362ee6b354c28da51272f45158a0e8286